All In Biotech

Drug Trial Radar · NCT01284647

A Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis

A Prospective, Randomized, Double-blind, Double-dummy, Sucralfate Controlled, Multicenter Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis

Last checked: Nov 20, 2026Latest source record: Jan 14, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 156 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

156

Actual

Start

Feb 2011

Primary completion

Oct 2012

Study completion Jun 2013

Sponsor

Lead sponsor
Changhai HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Eisai China Inc.
First posted
Jan 27, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of teprenone on chronic non-atrophic erosive gastritis and its therapeutic mechanism

Conditions

  • Chronic Erosive Gastritis

Interventions

  • Teprenone capsule and placebo of sucralfateDrug

    Teprenone 1 capsule (50mg)+placebo of sucralfate 4tab, tid×8 weeks.

  • Sucralfate and placebo of teprenoneDrug

    Placebo of teprenone 1 capsule+ sucralfate 4 tab(1.0), tid×8 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The difference of the modified Lanza score after 4 weeks of treatment between teprenone group and sucralfate groupTime frame: 0,4 weeks

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Tongren Hospital

    Beijing, Beijing Municipality, China

  • Zhongshan Hospital of Xiamen University

    Xiamen, Guangdong, China

  • First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

  • First Affiliated Hospital of Dalian Medical University

    Dalian, Liaoning, China

  • Changhai Hospital

    Shanghai, Shanghai Municipality, China

  • Shanghai Xinhua Hospital

    Shanghai, Shanghai Municipality, China

  • First Affiliated Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China

  • General Hospital of Tianjin Medical University

    Tianjin, Tianjin Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.